These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Current trends in epigenetic drug discovery. Stolfa DA; Einsle O; Sippl W; Jung M Future Med Chem; 2012 Oct; 4(16):2029-37. PubMed ID: 23157236 [TBL] [Abstract][Full Text] [Related]
4. Potential Epigenetic Targets for Combating Alzheimer's Disease. Pandey D; Pal T; Sharma A; Flora S Mini Rev Med Chem; 2021; 21(12):1527-1540. PubMed ID: 33371834 [TBL] [Abstract][Full Text] [Related]
5. Drug discovery, development and delivery in Alzheimer's disease. Brambilla D Pharm Res; 2017 Dec; 35(1):3. PubMed ID: 29288429 [No Abstract] [Full Text] [Related]
6. How to address the complexity of multi-targeted drug discovery for Alzheimer's disease? González JF; Sánchez-Montero JM Expert Opin Drug Discov; 2024 Oct; 19(10):1149-1152. PubMed ID: 39075884 [No Abstract] [Full Text] [Related]
7. Marked for death: targeting epigenetic changes in cancer. Pfister SX; Ashworth A Nat Rev Drug Discov; 2017 Apr; 16(4):241-263. PubMed ID: 28280262 [TBL] [Abstract][Full Text] [Related]
8. Recent progress in the discovery of epigenetic inhibitors for the treatment of cancer. Verma SK Methods Mol Biol; 2015; 1238():677-88. PubMed ID: 25421686 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome. Chatterjee P; Roy D; Rathi N J Alzheimers Dis; 2018; 61(1):53-65. PubMed ID: 29199645 [TBL] [Abstract][Full Text] [Related]
11. A map of Alzheimer's disease-signaling pathways: a hope for drug target discovery. Ogishima S; Mizuno S; Kikuchi M; Miyashita A; Kuwano R; Tanaka H; Nakaya J Clin Pharmacol Ther; 2013 May; 93(5):399-401. PubMed ID: 23511713 [TBL] [Abstract][Full Text] [Related]
12. Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla. Storck SE; Pietrzik CU Pharm Res; 2017 Dec; 34(12):2637-2651. PubMed ID: 28948494 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic Modulators as Potential Multi-targeted Drugs Against Hedgehog Pathway for Treatment of Cancer. Singh AN; Sharma N Protein J; 2019 Oct; 38(5):537-550. PubMed ID: 30993446 [TBL] [Abstract][Full Text] [Related]
14. [Epigenetic mechanisms of Alzheimer's disease and related drug research]. Gong HC; Wang YL; Wang HW Yao Xue Xue Bao; 2013 Jul; 48(7):1005-13. PubMed ID: 24133967 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy. Wang J; Yu JT; Tan MS; Jiang T; Tan L Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931 [TBL] [Abstract][Full Text] [Related]
17. The current landscape in Alzheimer's disease research and drug discovery. Devenish SRA Drug Discov Today; 2020 Jun; 25(6):943-945. PubMed ID: 32360713 [No Abstract] [Full Text] [Related]
18. Novel drug targets in acute leukemia. Stock W Clin Adv Hematol Oncol; 2015 Aug; 13(8):493-5. PubMed ID: 26351809 [No Abstract] [Full Text] [Related]
19. Epigenetic drugs in Alzheimer's disease. Cuadrado-Tejedor M; Oyarzabal J; Lucas MP; Franco R; García-Osta A Biomol Concepts; 2013 Oct; 4(5):433-45. PubMed ID: 25436752 [TBL] [Abstract][Full Text] [Related]
20. A systems approach to drug discovery in Alzheimer's disease. Shelanski M; Shin W; Aubry S; Sims P; Alvarez MJ; Califano A Neurotherapeutics; 2015 Jan; 12(1):126-31. PubMed ID: 25608936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]